Arrow Greentech Q2 & H1 FY27: Revenue up 69% to ₹173.3 Cr, PAT grows 97% to ₹52.5 Cr
Arrow Greentech reported H1 FY27 revenue of ₹173.3 crore, up 69% YoY. EBITDA grew 98% to ₹69.2 crore, with margins at 40%. PAT surged 97% to ₹52.5 crore, with margins at 30%. The High-Tech Product segment revenue increased 88% to ₹156.3 crore. The company secured four new patents.
The substantial growth in key financial metrics (revenue, EBITDA, PAT) and the strategic development through new patent grants are material events that are likely to have a significant positive impact on the company's valuation and investor sentiment.
The company reported significant year-on-year growth in revenue, EBITDA, and PAT, along with margin expansion and new patent grants, indicating strong operational and financial performance.
Arrow Greentech Limited announced its financial results for the second quarter and first half of FY27, reporting a robust performance. For the first half of FY27, the company achieved revenue from operations of ₹1,733 million (₹173.3 crore), a significant year-on-year growth of 69%. EBITDA stood at ₹692 million (₹69.2 crore), marking a 98% increase year-on-year, with EBITDA margins improving to 40% from 34% in H1 FY26. Profit After Tax (PAT) for the period was ₹525 million (₹52.5 crore), a 97% rise, with PAT margins expanding to 30% from 25% in the previous year.
The company's High-Tech Product segment demonstrated strong growth, with revenues increasing by 88% year-on-year to ₹1,563 million (₹156.3 crore). This growth is attributed to sustained investments in research and innovation. During the half-year, Arrow Greentech was granted four patents, three in India and one in Singapore, enhancing its intellectual property portfolio and supporting market expansion.
The Green Products segment also continued to perform well, driven by a consistent flow of orders and timely delivery commitments. Mr. Shilpan Patel, Chairman and Managing Director, expressed confidence in the company's performance, highlighting that the EBITDA and PAT for the first six months of FY27 have surpassed the entire fiscal year of FY26. He emphasized the company's focus on expanding its product portfolio globally and creating value for stakeholders.
What to do with a filing like this
Arrow Greentech Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Arrow Greentech Limited. Read the original for the full detail.